✦ LIBER ✦

Innovative treatment for clinically localized adenocarcinoma of the prostate: The future role of molecular imaging

✍ Scribed by D'Amico, Anthony V.; Debruyne, Frans; Huland, Hartwig; Richie, Jerome P.

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 110 KB
Volume: 41
Category: Article
ISSN: 0270-4137
DOI: 10.1002/(sici)1097-0045(19991101)41:3<208::aid-pros9>3.0.co;2-b

No coin nor oath required. For personal study only.

✦ Synopsis

CDI) has been suggested to be able to predict the biologic aggressiveness of pros-

📜 SIMILAR VOLUMES

Analyzing outcome-based staging for clin

Analyzing outcome-based staging for clinically localized adenocarcinoma of the prostate

✍ Anthony V. D'Amico; April Desjardin; Ming-Hui Chen; Steve Paik; Delray Schultz; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Background: A clinical staging system based on the prostate-specific antigen (psa) and the calculated prostate carcinoma volume (cvca) construct previously has been proposed. this study was performed to assess whether this proposed clinical staging system was valid in an independent surgical and

Nuclear morphometry predicts disease-fre

Nuclear morphometry predicts disease-free interval for clinically localized adenocarcinoma of the prostate treated with definitive radiation therapy

✍ Mark D. Hurwitz; Theodore L. DeWeese; Eva S. Zinreich; Jonathan I. Epstein; Alan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 2 views

Men treated for prostate cancer often have unexpected outcomes despite predictive models based on stage, grade and prostate-specific antigen (PSA). Previous results have indicated that nuclear morphometry can predict patient outcome in urologic malignancies. Application of this analytical method in